-
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
NCT07123038 ·
Phase: Not specified ·
Ages: 18 Years to 71 Years ·
Sex: All (male and female)
· California: San Francisco, Stanford
-
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
NCT06747949 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Covina, La Jolla
-
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
NCT06733935 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: Orange
-
A Study of AZD0120 in Autoimmune Diseases
NCT07295847 ·
Phase: Phase 1 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: Stanford
-
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
NCT07412704 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female)
· California: La Jolla, Loma Linda, Palo Alto
-
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
NCT07607964 ·
Phase: Phase 1 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: Tustin
-
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
NCT07137598 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: La Jolla, Los Angeles, Upland
-
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
NCT07409103 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: Tustin
-
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
NCT06972446 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Beverly Hills, Chula Vista, Huntington Beach, Thousand Oaks
-
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
NCT07276581 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: La Jolla, San Dimas, San Leandro
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT06916806 ·
Phase: Phase 1 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· California: La Jolla, Sacramento
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
NCT04238143 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 90 Years ·
Sex: All (male and female)
· California: Valencia
-
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Chula Vista, Covina, Los Alamitos, Los Angeles
-
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
NCT07163221 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Covina, Temecula
-
ConsideRAte Study - Splenic Stimulation for RA
NCT05003310 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 22 Years to 75 Years ·
Sex: All (male and female)
· California: Covina, Whittier
-
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
NCT06397677 ·
Phase: Not specified ·
Ages: 18 Years to 90 Years ·
Sex: All (male and female)
· California: San Francisco
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
NCT04748809 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: La Jolla
-
Exactech Shoulder Post Market Clinical Follow-up Study
NCT05603728 ·
Phase: Not specified ·
Ages: 21 Years and older ·
Sex: All (male and female)
· California: Laguna Woods, Redwood City, Stockton
-
FT839 in Autoimmune Diseases
NCT07800871 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· California: Fullerton
-
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 ·
Phase: Not specified ·
Ages: Up to 21 Years ·
Sex: All (male and female)
· California: Los Angeles, Palo Alto, San Diego, San Francisco
-
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
NCT07237659 ·
Phase: Phase 1 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: Apple Valley, Beverly Hills, Covina, Monterey Park
-
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
NCT07404865 ·
Phase: Phase 3 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: Beverly Hills
-
Physica System Total Knee Replacement Registry Study
NCT03048201 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 22 Years and older ·
Sex: All (male and female)
· California: Rancho Mirage
-
R-2487 in Patients With Rheumatoid Arthritis
NCT05961592 ·
Phase: Phase 1 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: San Diego
-
RA-PRO PRAGMATIC TRIAL
NCT04692493 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Los Angeles, Nipomo, Turlock, Woodland Hills
-
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
NCT07201558 ·
Phase: Phase 1 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female)
· California: Fullerton
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
NCT06902519 ·
Phase: Phase 1 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female)
· California: La Jolla, Palo Alto, Tujunga, Whittier
-
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
NCT06201416 ·
Phase: Phase 1 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female)
· California: San Francisco, Stanford
-
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Palo Alto, Sacramento
-
The Myelin Disorders Biorepository Project
NCT03047369 ·
Phase: Not specified ·
Ages: No age limits stated ·
Sex: All (male and female)
· California: Los Angeles, Orange, Palo Alto, Sacramento